SOPHARMA (SPH): SOPHARMA AD (110/2023) Notification from Rositsa Doneva under Art. 19 of Regulation (EU) No 596/2014 of 7 September 2023. - raport 110/2023
Raport ESPI
Report no 110/2023
Podstawa prawna: art. 56. 1. 2 of Act on Public Offering.
Notification from Rositsa Doneva under Art. 19 of Regulation (EU) No 596/2014 of 7 September 2023.